GCKR and chronic kidney disease: Other genetic abnormalities, such as transmembrane 6 superfamily member 2 (TM6SF2) and glucokinase regulator (GCKR) polymorphisms, have also been reported to be associated with the risk of both MAFLD and CKD [65,68,69,70].